Kinnate Biopharma

+$0.34 (+3.40%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KNTE and other ETFs, options, and stocks.

About KNTE

Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W.

CEO
Nima M. Farzan
Employees
61
Headquarters
San Diego, California
Founded
2018

KNTE Key Statistics

Market cap
454.29M
Price-Earnings ratio
—
Dividend yield
—
Average volume
173.28K
High today
$10.34
Low today
$9.89
Open price
$10.27
Volume
108.14K
52 Week high
$26.05
52 Week low
$7.29

KNTE Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.61 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure